The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel

Inherited predisposition occurs in 5–10% of all prostate cancer (CaP) patients, but the genes involved in conferring genetic susceptibility remain largely unknown. Several lines of evidence indicate that germline mutations in BRCA1 and BRCA2 might be associated with an increased risk for CaP. Three...

Descripción completa

Detalles Bibliográficos
Autores principales: Vazina, A, Baniel, J, Yaacobi, Y, Shtriker, A, Engelstein, D, Leibovitz, I, Zehavi, M, Sidi, A A, Ramon, Y, Tischler, T, Livne, P M, Friedman, E
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2000
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374645/
https://www.ncbi.nlm.nih.gov/pubmed/10945492
http://dx.doi.org/10.1054/bjoc.2000.1249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374645/
https://www.ncbi.nlm.nih.gov/pubmed/10945492
http://dx.doi.org/10.1054/bjoc.2000.1249

Ejemplares similares